For the past decade, AI in biotech hadn’t produced any new developable products or therapeutics. Annie Lamont says everything has changed in the last 2 years: “We're incredibly excited with our @chaidiscovery investment last year, which is now creating amazing models & products oriented towards drug design & discovery.” “We are intentionally going into that space, & are going to be deeper & deeper in it.”